📰 Eric Dobmeier News
Page 4 - Eric Dobmeier News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eric Dobmeier. Real-time updates on events, politics, business and more.
May 20, 2022
The AFFINITY IgAN cohort of 20 patients is fully enrolled, with 70% of patients in the study having baseline proteinuria over one gram per day despite...
May 19, 2022
All patients with IgAN in Cohort 1 have transitioned to subcutaneous (SC) dosing, and BION-1301 remains well-tolerated, with no serious adverse events...
April 18, 2022
SEATTLE, March 21, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development...
March 21, 2022
Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors - read this article along with other careers information, tips and advice on BioSpace
March 17, 2022
SEATTLE, March 17, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development...
January 25, 2022
SEATTLE, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development...
January 24, 2022
Chinook Therapeutics Announces Appointment of Charlotte Jones-Burton, M.D., M.S. as Senior Vice President of Product Development and Strategy - read this article along with other careers information, tips and advice on BioSpace
November 30, 2021
The news: Chinook Therapeutics on Tuesday announced the formation of SanReno Therapeutics, which will advance therapies for kidney disease in China, Hong Kong…
November 30, 2021
Chinook Therapeutics, Inc. has announced the formation of SanReno Therapeutics - a joint venture with an investor syndicate led by Frazier Healthcare Partners and Pivotal bioVenture Partners China - to develop, manufacture and commercialize kidney disease therapies in China.